China Resources Double-Crane Pharmaceutical Co.,Ltd. Sustainability Profile
China Resources Double-Crane Pharmaceutical Co., Ltd., commonly referred to as Double-Crane, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1999, the company has made significant strides in the development and production of a wide range of pharmaceutical products, including traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Double-Crane is dedicated to enhancing healthcare through innovative solutions. The company is renowned for its commitment to quality and research, offering unique formulations that cater to diverse medical needs. Notable achievements include its recognition as a leader in the integration of traditional and modern medicinal practices, solidifying its market position as a trusted provider in the healthcare sector.
DitchCarbon Score
How does China Resources Double-Crane Pharmaceutical Co.,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s reported carbon emissions
China Resources Double-Crane Pharmaceutical Co., Ltd., headquartered in CN, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of publicly available information suggests that the company may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As a result, the company's climate strategy remains unclear within the context of industry standards and expectations for sustainability.
How Carbon Intensive is China Resources Double-Crane Pharmaceutical Co.,Ltd.'s Industry?
How Carbon Intensive is China Resources Double-Crane Pharmaceutical Co.,Ltd.'s Location?
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
China Resources Double-Crane Pharmaceutical Co.,Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
